Aurora Cannabis (ACB) Gains from Investment Securities (2018 - 2024)
Aurora Cannabis (ACB) reported Gains from Investment Securities of $5.7 million for Q4 2024, up 279.96% year-over-year from $1.5 million in Q1 2024, and up 410.31% quarter-over-quarter from -$1.8 million in Q2 2024.
Aurora Cannabis (ACB) Gains from Investment Securities (2018 - 2024) Analysis & Trends
Aurora Cannabis (ACB) has 7 years of Gains from Investment Securities data on file, last reported at $5.7 million in Q4 2024.
- Gains from Investment Securities for Q4 2024 came in at $5.7 million, up 279.96% year-over-year; the trailing twelve-month figure through Dec 2024 was $3.3 million (up 113.7% YoY), and the FY2023 annual result was -$83378.7, down 103.15% from the prior year.
- Gains from Investment Securities rose to $5.7 million in Q4 2024 per ACB's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $5.7 million in Q4 2024 and troughed at -$22.8 million in Q3 2021.
- A 5-year average of -$3.9 million and a median of -$1.8 million in 2024 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2020 and 2024: Gains from Investment Securities tumbled 1264.9% in 2020, then soared 279.96% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$6.9 million in 2020, then soared by 87.39% to -$865529.7 in 2021, then surged by 403.21% to $2.6 million in 2022, then slumped by 221.11% to -$3.2 million in 2023, then soared by 279.96% to $5.7 million in 2024.
- Business Quant data shows ACB's Gains from Investment Securities at $5.7 million in Q4 2024, -$1.8 million in Q2 2024, and -$3.2 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.72 Mn |
| Dec 31, 2024 | 5.72 Mn |
| Jun 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -1.84 Mn |
| Dec 31, 2023 | -3.18 Mn |
| Dec 31, 2023 | -3.18 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Dec 31, 2021 | -865,529.67 |
| Dec 31, 2021 | -865,529.67 |
| Sep 30, 2021 | -22.83 Mn |
| Sep 30, 2021 | -22.83 Mn |
| Mar 31, 2021 | -580,722.85 |
| Mar 31, 2021 | -580,722.85 |
| Dec 31, 2020 | -6.87 Mn |
| Dec 31, 2020 | -6.87 Mn |
| Sep 30, 2020 | -6.58 Mn |
| Sep 30, 2020 | -6.58 Mn |
| Jun 30, 2020 | 456,522.10 |
| Jun 30, 2020 | 456,522.10 |